Re-thinking cell cycle regulators: The cross-talk with metabolism

Frontiers in Oncology

Volumn 3 JAN, Issue , 2013, Pages

  Fajas, Lluis ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Cdk4; Cell cycle; E2F1 transcription factor; Metabolism; Mitochondria

Indexed keywords

6 PHOSPHOFRUCTO 2 KINASE; CYCLIN D2; CYCLIN D3; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE 9; HISTONE DEACETYLASE 3; PYRUVATE DEHYDROGENASE KINASE 4; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1;

ADIPOGENESIS; CANCER CELL; CANCER GROWTH; CELL CYCLE REGULATION; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; DNA POLYMORPHISM; GENE EXPRESSION; GENE MUTATION; GLYCOLYSIS; HUMAN; INSULIN RELEASE; LIPOGENESIS; METABOLIC REGULATION; MITOCHONDRION; NONHUMAN; REVIEW;

EID: 84879911368     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00004     Document Type: Review

References (63)

1. Abella, A., Dubus, P., Malumbres, M., Rane, S. G., Kiyokawa, H., Sicard, A., et al. (2005). Cdk4 promotes adipogenesis through PPARgamma activation. Cell Metab. 2, 239-249.
2. Aguilar, V., and Fajas, L. (2010). Cycling through metabolism. EMBO Mol. Med. 2, 338-348.
3. Allard, M. F., Schonekess, B. O., Henning, S. L., English, D. R., and Lopaschuk, G. D. (1994). Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am. J. Physiol. 267, H742-H750.
4. Annicotte, J. S., Blanchet, E., Chavey, C., Iankova, I., Costes, S., Assou, S., et al. (2009). The CDK4-pRB-E2F1 pathway controls insulin secretion. Nat. Cell Biol. 11, 1017-1023.
5. Attwooll, C., Lazzerini Denchi, E., and Helin, K. (2004). The E2F family: specific functions and overlapping interests. EMBO J. 23, 4709-4716.
6. Bauer, D. E., Hatzivassiliou, G., Zhao, F., Andreadis, C., and Thompson, C. B. (2005). ATP citrate lyase is an important component of cell growth and transformation. Oncogene 24, 6314-6322.
7. Blanchet, E., Annicotte, J. S., Lagarrigue, S., Aguilar, V., Clape, C., Chavey, C., et al. (2011). E2F transcription factor-1 regulates oxidative metabolism. Nat. Cell Biol. 13, 1146-1152.
8. Cam, H., Balciunaite, E., Blais, A., Spektor, A., Scarpulla, R. C., Young, R., et al. (2004). A common set of gene regulatory networks links metabolism and growth inhibition. Mol. Cell 16, 399-411.
9. Chen, H. Z., Tsai, S. Y., and Leone, G. (2009). Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat. Rev. Cancer 9, 785-797.
10. Chen, Y. W., Zhao, P., Borup, R., and Hoffman, E. P. (2000). Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J. Cell Biol. 151, 1321-1336.
11. Choi, J. H., Banks, A. S., Estall, J. L., Kajimura, S., Bostrom, P., Laznik, D., et al. (2010). Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature 466, 451-456.
12. Dali-Youcef, N., Mataki, C., Coste, A., Messaddeq, N., Giroud, S., Blanc, S., et al. (2007). Adipose tissue-specific inactivation of the retinoblastoma protein protects against diabesity because of increased energy expenditure. Proc. Natl. Acad. Sci. U.S.A. 104, 10703-10708.
13. Darville, M. I., Antoine, I. V., Mertens-Strijthagen, J. R., Dupriez, V. J., and Rousseau, G. G. (1995). An E2F-dependent late-serum-response promoter in a gene that controls glycolysis. Oncogene 11, 1509-1517.
14. Dhup, S., Dadhich, R. K., Porporato, P. E., and Sonveaux, P. (2012). Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis. Curr. Pharm. Des. 18, 1319-1330.
15. Dyson, N. (1998). The regulation of E2F by pRB-family proteins. Genes Dev. 12, 2245-2262.
16. Fajas, L., Annicotte, J. S., Miard, S., Sarruf, D., Watanabe, M., and Auwerx, J. (2004). Impaired pancreatic growth, beta cell mass, and beta cell function in E2F1(-/-) mice. J. Clin. Invest. 113, 1288-1295.
17. Fajas, L., Egler, V., Reiter, R., Hansen, J., Kristiansen, K., Debril, M. B., et al. (2002a). The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation. Dev. Cell 3, 903-910.
18. Fajas, L., Landsberg, R. L., Huss-Garcia, Y., Sardet, C., Lees, J. A., and Auwerx, J. (2002b). E2Fs regulate adipocyte differentiation. Dev. Cell 3, 39-49.
19. Feldmann, G., Mishra, A., Hong, S. M., Bisht, S., Strock, C. J., Ball, D. W., et al. (2010). Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling. Cancer Res. 70, 4460-4469.
20. Franklin, D. S., Godfrey, V. L., Lee, H., Kovalev, G. I., Schoonhoven, R., Chen-Kiang, S., et al. (1998). CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev. 12, 2899-2911.
21. Garcia-Cao, I., Song, M. S., Hobbs, R. M., Laurent, G., Giorgi, C., de Boer, V. C., et al. (2012). Systemic elevation of PTEN induces a tumor-suppressive metabolic state. Cell 149, 49-62.
22. Georgia, S., and Bhushan, A. (2004). Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J. Clin. Invest. 114, 963-968.
23. Guo, J. Y., Chen, H. Y., Mathew, R., Fan, J., Strohecker, A. M., Karsli-Uzunbas, G., et al. (2011). Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 25, 460-470.
24. Hammerman, P. S., Hayes, D. N., Wilkerson, M. D., Schultz, N., Bose, R., Chu, A., et al. (2012). Comprehensive genomic characterization of squamous cell lung cancers. Nature 489, 519-525.
25. Hanse, E. A., Mashek, D. G., Becker, J. R., Solmonson, A. D., Mullany, L. K., Mashek, M. T., et al. (2012). Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4alpha. Cell Cycle 11, 2681-2690.
26. Hsieh, M. C., Das, D., Sambandam, N., Zhang, M. Q., and Nahle, Z. (2008). Regulation of the PDK4 isozyme by the Rb-E2F1 complex. J. Biol. Chem. 283, 27410-27417.
27. Iankova, I., Petersen, R. K., Annicotte, J. S., Chavey, C., Hansen, J. B., Kratchmarova, I., et al. (2006). Peroxisome proliferator-activated receptor gamma recruits the positive transcription elongation factor b complex to activate transcription and promote adipogenesis. Mol. Endocrinol. 20, 1494-1505.
28. Jensen, T. E., and Richter, E. A. (2012). Regulation of glucose and glycogen metabolism during and after exercise. J. Physiol. 590, 1069-1076.
29. Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., et al. (2005). AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell 18, 283-293.
30. Kiyokawa, H., Kineman, R. D., Manova-Todorova, K. O., Soares, V. C., Hoffman, E. S., Ono, M., et al. (1996). Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85, 721-732.
31. Kolwicz, S. C., Jr. and Tian, R. (2011). Glucose metabolism and cardiac hypertrophy. Cardiovasc. Res. 90, 194-201.
32. Korzelius, J., The, I., Ruijtenberg, S., Prinsen, M. B., Portegijs, V., Middelkoop, T. C., et al. (2011). Caenorhabditis elegans cyclin D/CDK4 and cyclin E/CDK2 induce distinct cell cycle re-entry programs in differentiated muscle cells. PLoS Genet. 7:e1002362. doi: 10.1371/journal.pgen.1002362
33. Kroemer, G., and Pouyssegur, J. (2008). Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13, 472-482.
34. Kuhajda, F. P. (2000). Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 16, 202-208.
35. Kushner, J. A., Ciemerych, M. A., Sicinska, E., Wartschow, L. M., Teta, M., Long, S. Y., et al. (2005). Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. Mol. Cell. Biol. 25, 3752-3762.
36. Kuznetsov, A. V., Winkler, K., Wiedemann, F. R., von Bossanyi, P., Dietzmann, K., and Kunz, W. S. (1998). Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse. Mol. Cell. Biochem. 183, 87-96.
37. Latres, E., Malumbres, M., Sotillo, R., Martin, J., Ortega, S., Martin-Caballero, J., et al. (2000). Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis. EMBO J. 19, 3496-3506.
38. Lilja, L., Yang, S. N., Webb, D. L., Juntti-Berggren, L., Berggren, P. O., and Bark, C. (2001). Cyclin-dependent kinase 5 promotes insulin exocytosis. J. Biol. Chem. 276, 34199-34205.
39. Liu, R., Tian, B., Gearing, M., Hunter, S., Ye, K., and Mao, Z. (2008). Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion. Proc. Natl. Acad. Sci. U.S.A. 105, 7570-7575.
40. Manning, B. D., and Cantley, L. C. (2007). AKT/PKB signaling: navigating downstream. Cell 129, 1261-1274.
41. Medes, G., Thomas, A., and Weinhouse, S. (1953). Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res. 13, 27-29.
42. Meenakshisundaram, R., and Gragnoli, C. (2009a). CDK4 IVS4-nt40G → A and T2D-associated obesity in Italians. J. Cell. Physiol. 221, 273-275.
43. Meenakshisundaram, R., and Gragnoli, C. (2009b). CDK4 IVS4-nt40 AA genotype and obesity-associated tumors/cancer in Italians - a case-control study. J. Exp. Clin. Cancer Res. 28, 42.
44. Naaz, A., Holsberger, D. R., Iwamoto, G. A., Nelson, A., Kiyokawa, H., and Cooke, P. S. (2004). Loss of cyclin-dependent kinase inhibitors produces adipocyte hyperplasia and obesity. FASEB J. 18, 1925-1927.
45. Okada, S., Yamada, E., Saito, T., Ohshima, K., Hashimoto, K., Yamada, M., et al. (2008). CDK5-dependent phosphorylation of the Rho family GTPase TC10(alpha) regulates insulin-stimulated GLUT4 translocation. J. Biol. Chem. 283, 35455-35463.
46. Ortega, S., Malumbres, M., and Barbacid, M. (2002). Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta 1602, 73-87.
47. Perry, J. R., and Frayling, T. M. (2008). New gene variants alter type 2 diabetes risk predominantly through reduced beta-cell function. Curr. Opin. Clin. Nutr. Metab. Care 11, 371-377.
48. Pizer, E. S., Thupari, J., Han, W. F., Pinn, M. L., Chrest, F. J., Frehywot, G. L., et al. (2000). Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. Cancer Res. 60, 213-218.
49. Sakamaki, T., Casimiro, M. C., Ju, X., Quong, A. A., Katiyar, S., Liu, M., et al. (2006). Cyclin D1 determines mitochondrial function in vivo. Mol. Cell. Biol. 26, 5449-5469.
50. Sarruf, D. A., Iankova, I., Abella, A., Assou, S., Miard, S., and Fajas, L. (2005). Cyclin D3 promotes adipogenesis through activation of peroxisome proliferator-activated receptor gamma. Mol. Cell. Biol. 25, 9985-9995.
51. Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I., Chen, H., et al. (2007). Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316, 1331-1336.
52. Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., et al. (2007). A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316, 1341-1345.
53. Shaw, R. J. (2006). Glucose metabolism and cancer. Curr. Opin. Cell Biol. 18, 598-608.
54. Sherr, C. J. (2012). Ink4-Arf locus in cancer and aging. Wiley Interdiscip. Rev. Dev. Biol. 1, 731-741.
55. Strock, C. J., Park, J. I., Nakakura, E. K., Bova, G. S., Isaacs, J. T., Ball, D. W., et al. (2006). Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells. Cancer Res. 66, 7509-7515.
56. Ubeda, M., Kemp, D. M., and Habener, J. F. (2004). Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic beta-cells. Endocrinology 145, 3023-3031.
57. Vander Heiden, M. G., Cantley, L. C., and Thompson, C. B. (2009). Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033.
58. Wang, R., Dillon, C. P., Shi, L. Z., Milasta, S., Carter, R., Finkelstein, D., et al. (2011). The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35, 871-882.
59. Warburg, O. (1930). Metabolism of Tumors. London: Arnold Constable.
60. Warburg, O. (1956a). On respiratory impairment in cancer cells. Science 124, 269-270.
61. Warburg, O. (1956b). On the origin of cancer cells. Science 123, 309-314.
62. Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X. Y., Pfeiffer, H. K., et al. (2008). Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl. Acad. Sci. U.S.A. 105, 18782-18787.
63. Zhang, J., Khvorostov, I., Hong, J. S., Oktay, Y., Vergnes, L., Nuebel, E., et al. (2011). UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells. EMBO J. 30, 4860-4873.